Cargando…
Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth
BACKGROUND: Peroxisome proliferator-activated receptors gamma (PPARγ) ligands have been shown to inhibit the growth of non-small cell lung cancer (NSCLC) cells. However, the mechanisms underlying this effect remain incompletely elucidated. METHODS: Cell proliferation and apoptosis were measured by c...
Autores principales: | Hann, SWei Sunny, Tang, Qing, Zheng, Fang, Zhao, Shunyu, Chen, Jianping, Wang, ZhiYu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061523/ https://www.ncbi.nlm.nih.gov/pubmed/24925061 http://dx.doi.org/10.1186/1476-4598-13-149 |
Ejemplares similares
-
Targeting 3-phosphoinositide-dependent protein kinase 1 by N-acetyl-cysteine through activation of peroxisome proliferators activated receptor alpha in human lung cancer cells, the role of p53 and p65
por: Hann, Swei Sunny, et al.
Publicado: (2013) -
β-elemene inhibited expression of DNA methyltransferase 1 through activation of ERK1/2 and AMPKα signalling pathways in human lung cancer cells: the role of Sp1
por: Zhao, ShunYu, et al.
Publicado: (2015) -
mRNA surveillance complex PELOTA–HBS1 regulates phosphoinositide-dependent protein kinase1 and plant growth
por: Kong, Wei, et al.
Publicado: (2021) -
Effect of ciglitazone on adipogenic transdifferentiation of bovine
skeletal muscle satellite cells
por: Zhang, Junfang, et al.
Publicado: (2021) -
Biological Roles and Mechanisms of Circular RNA in Human Cancers
por: Tang, Qing, et al.
Publicado: (2020)